This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.
Device | P170038S002 |
Classification Name | None |
Applicant | |
PMA | P170038 |
Supplement | S002 |
Supplement Number | Date | Supplement Type |
---|---|---|
P170038 | Original Filing | |
S010 | 2022-04-13 | 30-day Notice |
S009 | 2022-03-15 | 30-day Notice |
S008 | 2021-08-24 | 135 Review Track For 30-day Notice |
S007 | 2021-08-02 | Normal 180 Day Track No User Fee |
S006 | 2021-07-08 | 30-day Notice |
S005 | 2020-07-31 | Normal 180 Day Track No User Fee |
S004 | ||
S003 | 2020-04-01 | 30-day Notice |
S002 | ||
S001 | 2020-01-08 | Normal 180 Day Track No User Fee |